ARKG is trading at $47.59, up 4.72%, amid a healthcare-sector tailwind tied to reported optimism about potential healthcare-spending and coverage-policy changes after the Democratic midterm sweep. - Healthcare stocks were rising premarket, though gains were uneven across names; this is a sector backdrop, not a confirmed ARKG-specific catalyst. - The broad market rebound may also support risk appetite: the S&P 500 was up 1.91% and Nasdaq Composite up 2.41%. No single ARKG holding is established as the cause.